Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1058 Optimal antitumor immunity triggered by WTX-124, a clinical stage conditionally activated INDUKINETM molecule that releases fully potent IL-2 in the tumor microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.
